Ameena El-Bibany

Ameena is a Principal at Artis Ventures and currently sits on the Board of Activ Surgical. Prior to joining, she spent 5 years in early stage venture capital as a Partner at Rising Tide VC, where she built and led the firm’s health and bio investment practice and invested in companies including Precision NanoSystems (acquired by Danaher), Apama Medical (acquired by Boston Scientific), Evonetix, Exo Imaging, Loop Genomics, Aspect Biosystems, Atia Vision and others. Focusing on the intersection of science and technology, she has invested in and worked with companies spanning personalized medicine, synthetic biology, computational biology and more. She is passionate about bridging academia and industry to create lasting impact.

Ameena began her career in R&D, working at Novozymes, a world leader in bio innovation, to develop procedures for maximizing yield through industrial scale up. She is a recipient of multiple competitive grants funded by the National Science Foundation for research done at the California Academy of Sciences and the Bermuda Institute of Ocean Sciences, as well as an awardee of the National Science Foundation Graduate Research Fellowship Program.

She has conducted research across DNA damage and repair in longevity, microbiome diversity, and stem cell induction and stabilization. Ameena holds a BS in Genetics from the University of California, Dav